Sarepta Therapeutics, Inc.
看多

Moving towards 135 ceiling on trend established here

73
With indicators screaming for a run-up before a better earnings report than the last one, this gives us a better perspective on whether the company can turn around results. However, I wouldn't be so confident if it continues declining below 120.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。